GMP partner manufacturing, HSA registration and licensed wholesale distribution, managed from Singapore. Manufacturing happens at qualified partner sites; registration, quality review and supply are handled by our Singapore team.
Founder-ledRishi NandirajuNUS Chemical Engineering · iDP award 2024
Therapeutic Products Wholesaler’s Licence on the public HSA register.
HSA licence list →Exclusive Nasodine licence from Firebrick Pharma (ASX:FRE), Aug 2025.
ASX announcement →Pick the route that matches your situation. Each one goes straight to the page that answers it.
Classification, CTD/ACTD dossier, HSA evaluation routes and timelines.
HSA registration → Brand ownersOEM and private-label manufacturing through qualified GMP partners.
OEM & private label → Doctors & clinicsHow the Special Access Route works, the forms, and what we handle for you.
SAR, step by step → Licensors & partnersSee how we took Nasodine to an exclusive four-market licence in 10 months.
Read the case study →INNORINI PTE. LTD. (UEN 202015523Z) is a Singapore pharmaceutical company founded in 2020 by Rishi Nandiraju. It provides pharmaceutical OEM and private-label manufacturing through qualified GMP partners, HSA registration and regulatory affairs, Special Access Route support, unit-dose packing and licensed wholesale distribution in Singapore, from 1 Clementi Loop, #05-02 Clementi West LogisPark, Singapore 129808.
Six services that cover the full route to market. Use one, or let us run the whole project.
Tablets, capsules, powders, liquids and topicals made under your brand by qualified GMP partners, with Singapore project and quality oversight.
OEM services →Classification, gap analysis, ICH CTD or ASEAN CTD dossier, submission and query management with Singapore’s Health Sciences Authority.
Registration support →
03 · Patient accessUnregistered medicines for named patients, when no registered alternative exists.
Formulation, manufacturing and HSA-compliant labelling, from the team behind PartyPal.
Private label → 05 · Market accessLicensed wholesale distribution in Singapore, with import, labelling and channel set-up.
Import guide → 06 · PackagingIndividually sealed, labelled pouches by patient and time, packed in Singapore.
Unit-dose packing → Not sure where to start?When no suitable registered alternative exists in Singapore, HSA’s Special Access Route (SAR) lets a licensed importer bring the medicine in for your patient. We prepare the application with your Signed Request Form and coordinate sourcing and delivery to your clinic.
Source: HSA, import and supply of unregistered therapeutic products
Eight steps, with every hand-off visible. We tell you upfront which work happens in Singapore and which happens at our GMP manufacturing partners.
We assess your product, target markets and regulatory route under a confidentiality agreement.
SingaporeWe confirm the HSA category (therapeutic product, health supplement or other) and the evaluation route.
SingaporeSpecifications, quality agreement and tech transfer are agreed with the manufacturing site.
GMP partnerProduction with batch documentation and a certificate of analysis for each batch.
GMP partnerDossier compiled in ICH CTD or ASEAN CTD format, submitted, and queries answered.
SingaporeLabel finalisation, import permits and customs clearance once the product is approved.
SingaporeIncoming quality review, storage and, where needed, unit-dose packing.
Clementi, SingaporeWholesale supply, variations, renewals and safety reporting after launch.
Singapore
Rishi Nandiraju founded Innorini in June 2020 and leads the company as Managing Director. He studied Chemical Engineering at the National University of Singapore (NUS) with a second major in the Innovation & Design Programme (iDP), and applies design thinking to every product brief.
His time as an SCDF Rota Commander showed him the physical demands on frontline personnel, which led to Innorini’s first formulation, the Innolyte oral rehydration range. His final-year project, the Innolax range, won the Most Innovative Project Award at the NUS iDP Project Showcase 2024. Today he leads Innorini’s partnerships, including the exclusive Nasodine licence with ASX-listed Firebrick Pharma.
“Constantly innovate with blue ocean ideas in the realm of pharmaceuticals and nutraceuticals to enhance user wellbeing.”Innorini mission statement
Every credential below links to the organisation that published it, so you can check it yourself.
The Innolax range began as Rishi’s final-year project in the NUS Innovation & Design Programme and was named the showcase’s Most Innovative Project. NUS documents the project and its founder on its own site.
Source: NUS College of Design and Engineering →Innorini has been an excellent partner for us in Singapore.
The companies and channels Innorini works with. Each card links to a public source you can check.
ASX:FREAustralian developer of Nasodine. Appointed Innorini exclusive licensee for four markets in August 2025.
ASX, 26 Aug 2025 →
Distribution partner for Nasodine in Singapore. Innorini manages the relationship under the licence.
ASX, 26 Aug 2025 →
Nasodine on Guardian pharmacy shelves in Singapore since January 2025.
Firebrick half-year report →
Singapore online medical supplies store stocking PartyPal and Nasodine.
PartyPal on EMIS+ →
TraphouseAustralian retailer selling PartyPal in 5-sachet packs and full 20-sachet boxes.
PartyPal on Traphouse →Nasodine Nasal Spray and Throat Spray available to order online in Singapore.
nasodine-sg.com →Nasodine Throat Spray promoted to government hospitals and healthcare professionals from late 2025.
ASX, 21 Jan 2026 →NUS iDP Most Innovative Project Award 2024 for the Innolax range.
NUS project page →Products on the Singapore market today: three of Innorini’s own formulations and one licensed brand.
Sugar-free melt-in-mouth granules built on Innorini’s ORAMELT and C3 CURA technologies.
Psyllium-based digestive health range that won the NUS iDP Most Innovative Project Award 2024.
Enriched oral rehydration salts, Innorini’s first product line.
0.5% povidone-iodine antiseptic nasal spray by Firebrick Pharma, licensed exclusively to Innorini in four markets.
Two formulation technologies, both commercially used in PartyPal and available to partners under licence.
Singapore’s regulator is recognised at the highest international level, and its dossier formats travel well across ASEAN.
Sources: HSA WLA announcement · HSA fees and turnaround times · HSA application dossier
Practical guides for companies bringing medicines and supplements into Singapore.
Classification, dossier, evaluation routes, timelines and post-market duties.
Read the guide →Licences, product registration, customs, cold chain and the Special Access Route.
Read the guide →HSA’s voluntary notification scheme, ingredients, labelling and claims.
Read the guide →